HomeATNM • NYSEAMERICAN
add
Actinium Pharmaceuticals Inc
Previous close
$1.68
Day range
$1.63 - $1.68
Year range
$1.03 - $2.41
Market cap
50.85M USD
Avg Volume
161.42K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.50M | -39.58% |
Net income | -6.88M | 39.42% |
Net profit margin | — | — |
Earnings per share | -0.22 | 42.11% |
EBITDA | -7.30M | 40.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.93M | -30.35% |
Total assets | 63.02M | -29.87% |
Total liabilities | 44.00M | -4.39% |
Total equity | 19.01M | — |
Shares outstanding | 31.20M | — |
Price to book | 2.75 | — |
Return on assets | -28.49% | — |
Return on capital | -79.10% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.88M | 39.42% |
Cash from operations | -5.39M | 32.36% |
Cash from investing | — | — |
Cash from financing | -3.00K | -100.03% |
Net change in cash | -5.40M | -372.20% |
Free cash flow | -3.26M | 42.00% |
About
CEO
Founded
2000
Website
Employees
27
